Quoin Pharmaceuticals, Ltd.
QNRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$9,005 | -$8,687 | -$9,381 | -$21,463 |
| Dep. & Amort. | $100 | $104 | $104 | $104 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,259 | $1,095 | $764 | $0 |
| Change in WC | -$2 | $95 | -$94 | $632 |
| Other Non-Cash | -$209 | -$471 | $127 | $15,006 |
| Operating Cash Flow | -$7,857 | -$7,864 | -$8,481 | -$5,720 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$250 | -$625 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$17,254,282 | -$18,044 | -$9,899 | $0 |
| Inv. Sales/Matur. | $26,933,736 | $20,227 | $14,877,332 | $0 |
| Other Inv. Act. | -$9,681,342 | $6 | -$14,877,332 | $0 |
| Investing Cash Flow | -$1,888 | $2,188 | -$10,149 | -$625 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$600 | -$600 | -$312 | $3,475 |
| Stock Issued | $11,623 | $5,834 | $14,819 | $0 |
| Stock Repurch. | $0 | $0 | -$14,819 | $0 |
| Dividends Paid | $0 | $0 | -$65,266 | $0 |
| Other Fin. Act. | -$55 | -$18 | $64,766 | $10,029 |
| Financing Cash Flow | $10,968 | $5,217 | $14,008 | $13,504 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1,222 | -$459 | -$4,622 | $7,159 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,401 | $2,861 | $7,483 | $324 |
| End Cash | $3,623 | $2,401 | $2,861 | $7,483 |
| Free Cash Flow | -$7,857 | -$7,864 | -$8,731 | -$6,345 |